We have constructed an artificial ligand for the hepatocyte-specific asialoglycoprotein receptor for the purpose of generating a synthetic delivery system for DNA. This ligand has a tetra-antennary structure, containing four terminal galactose residues on a branched carrier peptide. The carbohydrate residues of this glycopeptide were introduced by reductive coupling of lactose to the a-and €-amino groups of the two N-terminal lysines on the carrier peptide. The C-terminus of the peptide, containing a cysteine separated from the branched N-terminus by a 10 amino acid spacer sequence, was used for conjugation to 3-(2-pyridyldithio)propionate-modified polylysine via disulfide bond formation. Complexes containing plasmid DNA bound to these galactose-polylysine conjugates have been used for asialoglycoprotein receptor-mediated transfer of a luciferase gene into human (HepG2) and murine (BNL CL.2) hepatocyte cell lines. Gene transfer was strongly promoted when amphipathic peptides with pH-controlled membrane-disruption activity, derived from the N-terminal sequence of influenza virus hemagglutinin HA-2, were also present in these DNA complexes. Thus, we have essentially borrowed the small functional domains of two large proteins, asialoglycoprotein and hemagglutinin, and assembled them into a supramolecular complex to generate an efficient gene-transfer system.
INTRODUCTION
During the last few years gene-transfer methods have been developed that adopt natural receptor-mediated endocytosis pathways for the delivery of DNA into eukaryotic cells. Ligands for cellular receptors, such as transferrin (1, 2) , viral proteins (3), insulin bound to albumin (4), or asialoorosomucoid (5, 6) have been successfully used for the import of DNA molecules. For this purpose these ligands have been conjugated to DNAbinding compounds, such as a polycation or an intercalating agent. Incubating DNA with these protein conjugates generates ligand-coated DNA which can bind receptors on the cell surface and is subsequently internalized. Small synthetic, rationally designed compounds that bind specifically to a cellular receptor may be useful, well-defined alternatives for large protein ligands.
In this paper we describe the synthesis of polylysine conjugates containing an artificial ligand for the asialoglycoprotein receptor (7). This hepatocyte-specific receptor recognizes exposed galactose on serum glycoproteins that have lost the terminal sialic acids and rapidlyremoves these glycoproteins from the circulation to the liver. The artificial ligand we designed displays four galactoside residues on a branched carrier peptide possessing a C-terminal cysteine as a ligation site for coupling to the DNA-binding polycation polylysine. Using this proteinfree, synthetic polylysine conjugate, luciferase gene transfer into cultured hepatocytes is possible with an efficiency similar to that achieved with a natural ligand, asialofetuin, conjugated to polylysine. One limit to receptor-mediated gene delivery may be the accumulation of the delivered DNA complexes in intracellular vesicles (2, 3, 8) . To overcome this barrier, we have developed strategies that utilize the endosome disruption activity of either defective adenovirus particles (9, 10) or synthetic, amphipathic peptides (111, derived from the N-terminus of the influenza virus hemagglutinin HA-2 protein (12) . Further goals of this work have been to prepare DNA complexes containing both the synthetic galactose-ligand and the amphipathic peptides, and to subsequently investigate whether these protein-free DNA complexes have improved gene transfer efficiencies.
EXPERIMENTAL PROCEDURES
Materials and Conjugates. The DNA plasmid pCMVL, containing the Photinus pyralis luciferase gene under control of the cytomegalovirus enhancer/promoter, was prepared by removing the BamHI insert of the plasmid pSTCX556 (131, treating the plasmid with Klenow fragment, and ligating with the HindIIIISspI and Klenowtreated fragment from the plasmid pRSVL (14) , which contains the sequence coding for luciferase. Human transferrin-poly@-lysine) conjugates with an average chain length of 190 lysines (TfpL19Ol) or 290 lysines (TfpL290) were prepared as described (15) . Mouse transferrin-poly-(L-lysine) conjugates (mTfpL290) were synthesized using the method described in ref 1. Conjugate InflupL, containing the peptide derived from influenza virus hemagglutinin (Gly-Leu-Phe-Glu-Ala-Ile-Ala-Gly-Phe-IleGlu-Asn-Gly-Trp-Glu-Gly-Met-Ile-Asp-Gly-Gly-GlyCys) coupled to polylysine plysaw, was synthesized as described in ref 11 . Synthesis of N'-lactosylated polylysine (pLys-lactose) was performed as follows: to a solution of 16.5 mg (0.44 pmol) of pLyszw, acetate salt, in 0.46 mL of 100 mM sodium acetate (pH 5.0) was added 90 mg (0.26 mmol) of lactose (Sigma), which dissolved upon agitating within 30 min at 37 "C. The solution was kept at this temperature while four 3-mg portions of sodium cyanoborohydride were added in about 10-h intervals. The reaction mixture was left for an additional 21 h a t 37 "C; then 15 pL of acetic acid was added, and the reaction Abbreviations used: TfpL, transferrin-poly(L-lysine) conjugate; AFpL, asialofetuin-poly(L-lysine) conjugate; pLyszoo and pLys2~0, poly(L-lysine) with an average chain length of 200 or 290 lysine monomers; HEPES, 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid; HBS, HEPES-buffered saline (150 m M NaCl, 20 mM HEPES, pH 7.3).
mixture was subjected to gel filtration (Sephadex G25-PD10) in 100 mM sodium acetate (pH 5.0). The productcontaining fraction (identified by ninhydrin assay and staining with anisaldehyde after spotting l-pL samples on TLC plates) was dialyzed against 20 mM sodium acetate overnight and then against 0.05% acetic acid. Lyophilization gave 26 Assays. The amount of dithiopyridine linkers in modified asialofetuin or polylysine was determined after reduction of an aliquot with dithiothreitol followed by absorption measurement of released pyridine-Qthione at 340 nm. The polylysine content of fractions was estimated spectrophotometrically by ninhydrin assay. The amount of free mercapto groups in modified polylysine or peptides was determined using 5,5'-dithiobis(2-nitrobenzoic acid) (16) and measurement at 412 nm. The asialofetuin content of fractions was determined by UV measurement at 280 nm and correction of the value (where necessary) by substraction of the corresponding UV absorption of dithioppidine or buffer at 280 nm. Lactosylation was monitored by staining with anisaldehyde reagent @-anisaldehyde/sulfuric acid/ethanol, 1/ 1/ 18) on TLC plates (silica gel), by 'H-NMR analysis, and/or spectrophotometrically by the anthron assay (17) using lactosylated polylysine as standard.
Asialofetuin-Polylysine Conjugate Synthesis. Asialofetuin-polylysine conjugate ( AFpL) was synthesized by coupling asialofetuin to polylysine via disulfide bonds after modification of asialofetuin with the bifunctional reagent succinimidyl3-(2-ppidyldithio)propionate (SPDP, Pharmacia) in asimilar fashion as described (I). To a solution of 100 mg (2.2 pmol) of asialofetuin (Sigma) in 4 mL of 100 mM HEPES buffer, pH 7.9, was added 330 pL of a 15 mM ethanolic solution of SPDP (5.0 pmol) with vigorously mixing. After 1 h at room temperature, purification was performed by gel filtration (Sephadex G25; 100 mM HEPES buffer, pH 7.9) to give 5 mL of a solution of 1.4 pmol of asialofetuin modified with 2.25 pmol of dithiopyridine linker. This solution was mixed under an argon atmosphere with a solution of 0.33 pmol of poly(L-lysine) with an average chain length of 190 lysine monomers ( p L y s l~) , modified with 1.07 pmol of 3-mercaptopropionate groups as described in ref 1, in 6.5 mL of 200 mM HEPES buffer, pH 7.6. The reaction mixture was kept for 24 h at room temperature. Conjugates were isolated from the reaction mixture by cation-exchange chromatography (Mono S column HR 10/10, Pharmacia; gradient elution with buffer A, 50 mM HEPES, pH 7.9, and buffer B, buffer A plus 3 M NaC1). Sodium chloride was added to the reaction mixture (final concentration 0.6 M) before loading the column, and the gradient was started at this salt concentration. The product was eluted at a NaCl concentration of ca. with a solution of 7.85 mg (23 pmol) of lactose in 40 pL of 10 mM aqueous sodium acetate, pH 5 at 37 "C. To the solution were added four 0.6 mg (10 pmol) portions of sodium cyanoborohydride at 10-h intervals. After a total of 64 h at 37 "C, 0.5 mL of HEPES, pH 7.3, and 15 mg of dithiothreitol were added. After 30 min, fractionation by gel filtration (Sephadex G10,12 X 130 mm, eluent 20 mM NaC1) under argon yielded a 3.6-mL solution of lactosylated peptide lb in the free mercapto form (1.73 pmol, according to an assay withEllman's reagent, an 84% yield). Samples of the modified peptide showed a color reaction with anisaldehyde, but no color reaction with ninhydrin; this is consistent with the assumption that all four N-terminal amino groups have been lactosylated. 'H-NMR analysis (D20, 250 MHz, solvent suppression) demonstrated that the group of five a-H signals, 6 (ppm) = 4.58 (1 H, Cys), 4.52 (3 H, 3 Ser), 4.35 (1 H, Lys), found in the spectrum of the precursor peptide is overlaid by the signal of four galactose-1H protons at 4.51 ppm (4 H). Time-of-flight mass spectrum performed with a Bio Ion 252Cf PD-MS instrument (Uppsala, Sweden) showed a major mass peak of 2473 (MH+ of product lb) and a minor peak of 2146 (presumably traces of tris-lactosylated peptide). (C) Conjugation of Peptide withPolylysine. Conjugates were prepared by mixing 1.5 pmol of lactosylated peptide lb in 3 mL of 20 mM NaCl with 0.146 pmol of modified polylysine 2 in 620 pL of 100 mM sodium acetate buffer, pH 5, under an argon atmosphere. After the addition of 100 pL of 2 M HEPES, pH 7.9, the reaction mixture was kept for 18 h at room temperature. The salt concentration was brought to 0.66 M by addition of NaC1, and conjugates were isolated by cation-exchange chromatography (Pharmacia Mono S column HR 5/5; gradient elution with buffer A, 50 mM HEPES, pH 7.3, and buffer B, buffer A plus 3 M NaCl). The product fractions were eluted at salt concentrations around 1.2-1.8 M and pooled. After dialysis against 25 mM HEPES, pH 7.3, conjugate 3, "(gal)4pL", was obtained, containing 49 nmol of pLys2~0 modified with ca. 380 nmol of ligand moieties (Le. 1.5pmol of lactosamine groups).
Cells and Transfections. HepG2 cells (ref 20
, a kind gift of Prof. M. Spiess, Basle) were grown in DMEM plus 10% FCS, 100 units/mL penicillin, 100 pg/mL streptomycin, and 2 mM glutamine in 25 cm2 flasks. The mouse embryonic liver cell line BNL CL.2 (ATCC TIB 73; ref 21 ) was grown in 6-cm plates in high glucose DMEM (0.4% glucose) supplemented with 10 % heat-deactivated FCS, with 100 units/mL penicillin, 100 pg/mL streptomycin, and 2 mM glutamine at 37 "C in a 5% COz atmosphere. Transfections were performed at a density of 300 000-400 000 cells per flask (or plate). Before transfection, cells were supplied with fresh serum-supplemented medium. The cells were harvested for the luciferase assay (3) 24 
RESULTS
Synthesis. We wanted to construct a tetra-antennary ligand containing four galactoside residues that should serve for binding to the asialoglycoprotein receptor. For this purpose, the branched peptide la (see Figure 1 ) was prepared by automated solid-phase synthesis using the Fmoc procedure (18) . Branching at the N-terminus was the result of coupling two lysines to the a-and €-amino groups of a further lysine, utilizing a concept similar to that described for the preparation of MAPS (multiple antigenic peptides, ref 22) . The four amino groups of la were modified with lactose (0.6 M lactose, i.e. 12 equiv/ peptide; 37 "C) by aldimine formation followed by reduction with sodium cyanoborohydride to the secondary amines. The resulting glycopeptide lb, containing the clustered carbohydrate groups separated from a C-terminal cysteine by a 10 amino acid long Gly/Ser spacer sequence, was isolated in the reduced, sulfhydryl-containing form. Modification of all four amino groups was indicated by a ninhydrin assay and confirmed by proton NMR analysis and time-of-flight mass spectroscopy. The C-terminal cysteine served for coupling to pyridyldithiopropionatemodified polylysine 2 (average chain length of ca. 290 L-lysine monomers per molecule) via disulfide bond formation in the next step. Conjugate 3, "(gal)4pL", was isolated by ion-exchange chromatography and characterized by determination of lysine and carbohydrate content. The conjugate contains, on average, 8 glycopeptide ligands per polylysine chain, which corresponds to 1 ligand per 36 lysine residues.
As reference compounds, asialofetuin-polylysine conjugates, AFpL, and Ne-lactosylated polylysine, pLyslactose, were synthesized (see Experimental Procedures). The synthesis of AFpL conjugates involved the modification of one to two amino groups on the asialofetuin molecule with succinimidyl3-(2-pyridyldithio)propionate, followed by ligation to similarly modified polylysine 2 through the formation of disulfide bonds. N'-Lactosylated polylysine was prepared by reductive coupling of lactose to the polylysine amino groups. The chosen conditions Figure 2 ). These complexes were applied onto HepG2 cells (which express high levels of the asialoglycoprotein receptor); the cells were harvested 24 h later and assayed for luciferase activity. Expression of luciferase ( Figure 21 , as an indication of successful gene transfer into HepG2 cells, was found using transferrin, asialofetuin, or the artificial galactose-containing peptide as ligands (Figure 2, lanes 1-3) , but only if the cells were also incubated in the presence of the lysosomatropic agent chloroquine, which prevents acidification and activation of lysosomal degradative enzymes, but may also act by osmotic destabilization of intracellular acidic vesicles upon internal accumulation of the agent (2-3,8,23) . The Augmentation of Gene Delivery by ReplicationDefective Adenovirus Particles. Gene transfer into the murine embryonic hepatocyte line BNL CL.2 is shown in Figure 3 . Again, complexes containing the hepatocytespecific ligands, AF or (gal)4, showed the highest gene transfer activities in the presence of chloroquine ( Figure  3B ). In the absence of chloroquine only modest expression levels ( Figure 3A ) near the background of 150-200 light units were obtained. Although the plasmid DNA pCMVL, containing the P. pyralis luciferase gene under control of the more efficient cytomegalovirus immediate-early promoter/enhancer, was used, the transfection efficiencies have been moderate even in the presence of chloroquine. An alternate measure to prevent accumulation of the delivered DNA in intracellular vesicles is the use of replication-defective adenoviruses, which, as a result of their endosome-disrupting activity, have been found to strongly enhance transferrin-polylysine-mediated gene transfer into HeLa cells (9) . Addition of adenovirus d1312 particles to the transfection medium resulted in a strong augmentation of gene expression both in BNL CL.2 cells ( Figure 3C ) and HepG2 cells (data not shown). The augmentation (30-500-fold over the level of chloroquineaugmented transfections, ca. 106-fold over the level of control transfections) was most pronounced in the case of polylysine-rich DNA complexes ( Figure 3C , "(gal)4pL"), which tend to bind adenovirus particles by ionic interaction between polylysine and the acidic viral capsid proteins (our unpublished observations). DNA/transferrin-polylysine complexes which are physically linked to the virus (10) have been found to be a most efficient means for gene transfer, as colocalization of the DNA complex and virus particle in the same endosome is guaranteed.
Enhanced Gene Transfer Using DNA Complexes Containing Galactose-Ligand and Influenza Peptides. Polylysine-conjugated peptides containing sequences derived from the N-terminus of the influenza virus hemagglutinin HA-2 subunit have been found to substantially augment transferrin-polylysine-mediated gene transfer (11) . We have prepared similar complexes ( Figure  4A ) containing the plasmid pCMVL, the tetra-antennary galactose ligand linked to polylysine, and the polylysinemodified influenza peptide InflupL (see Experimental Procedures and ref 11). Conditions were chosen so that the ligand-polylysine conjugate neutralized half of the DNA charge and the remainder of the charge was used to load the complexes with influenza peptide-polylysine conjugate. Delivery of these complexes into BNL CL.2 hepatocytes resulted in luciferase gene expression ( Figure  4B ) that was significantly higher than the expression obtained with transferrin as ligand. The expression was more than 500-fold higher than in control experiments using DNA complexes lacking the influenza peptides, but containing the same amount of transferrin or (gal)4pL conjugates and polylysine ( Figure 4B ). The activity obtained in the presence of the modified influenza peptide was ca. 10-fold higher than that obtained with DNA/(gal)-4pL complexes incubated with cells in the presence of chloroquine (see Figure 3B) , and ca. 104-fold higher than in the control experiment ( Figure 3A ).
DISCUSSION
Our aim is to develop a synthetic gene transfer system based on receptor-mediated endocytosis, a natural mechanism that is utilized for uptake of macromolecules such as proteins or viruses into cells. For this purpose, a number of groups (4,6,24), including our own, have synthesized DNA-binding conjugates of proteins that are ligands for cellular receptors. When DNA complexes prepared with the iron transporter transferrin, conjugated to polycations or other DNA-binding components (1,15) , are incubated with cells, the complexes bind to transferrin receptors, and subsequent uptake into the cells results in expression of the gene contained on the DNA (2,25) . In many cases the protein conjugation chemistry is difficult to control in terms of positions and numbers of polycation ligation sites, as a consequence of multiple potential reactive groups on the large protein ligands. In the case of transferrin conjugates, a specific ligation procedure involving modification of the transferrin carbohydrate moiety has been described (15) which allows defined, site-specific polycation attachment.
Another approach to obtain structurally well-defined DNA-binding ligand conjugates is the replacement of large protein ligands by smaller, synthetic compounds that mimic ligand-binding to a receptor. For this purpose we have synthesized an artificial ligand for the asialoglyco- protein receptor. This hepatocyte-specific receptor has already proven to be suitable for gene delivery using asialoorosomucoid-polylysine conjugates (5). The interaction of this receptor with its ligand is well-studied and occurs via recognition of (preferentially) three terminal galactose residues on the asialoglycoprotein ligand by the trimeric subunits of the receptor (7). Triantennary or tetra-antennary oligosaccharides (that are present, for example, on asialofetuin or asialo-orosomucoid) with three or four terminal galactose residues are rapidly endocytosed by hepatocytes, whereas there is no evidence of efficient endocytosis of biantennary oligosaccharides (26) or asialoglycoproteins containing biantennary oligosaccharides (27). The clustering effect has also been described for the binding of neoglycoproteins containing covalently attached synthetic galactosides at various sugar densities (28) . Synthetic cluster glycosides containing three galactosyl or lactosyl residues are bound to the asialoglycoprotein receptor and endocytosed by hepatocytes (29, 301 . We have synthesized a tetra-antennary ligand, (gal)4, containing galactoside residues bound to a branched peptide backbone which should provide appropriate structural arrangement of the carbohydrate groups ( Figure  1 ). This synthetic ligand, if conjugated to polylysine, binds to DNA and delivers the gene contained on the DNA into cultured hepatocytes. The uptake most likely proceeds through binding to the asialoglycoprotein receptor followed by endocytosis, because the gene expression can be inhibited by addition of compounds that compete for binding to the asialoglycoprotein receptor (Figure 2) .
After endocytosis, in the natural context, asialoglycoproteins are targeted to lysosomes and degraded by hydrolytic enzymes. The accumulation in lysosomal compartments may present a major limit to receptormediated gene delivery. A related hurdle seems to be present in the case of gene transfer by calcium phosphate precipitation, where over 50% of the DNA was found degraded in lysosomes (31) . Nevertheless, successful receptor-mediated gene transfer has been found using asialoorosomucoid-polylysine conjugates (5, 6) . In our hands, the expression levels in hepatocyte gene transfer experiments with asialofetuin or the (gal14 conjugates were very low unless further supporting measures (see below) were taken. Some rationalizations for the difference to the published data (5,6) are as follows: (i) we are working with a slightly different system (ligand, conjugate, reporter gene, complex formation, amount of reagents, cell culture conditions); (ii) we believe that the gene transfer in the published system (5,6) may be considerably augmented by the use of supporting agents such as chloroquine or adenovirus. In our experiments, efficient gene transfer was found when we included either chloroquine, which may protect to some extent internalized material from lysosomal degradation and/or may destabilize intracellular vesicles, or agents that promote the release of internalized DNA complexes from endosomes. A particularly effective measure consists of the use of defective adenovirus particles with endosome-disruption activity (9, 321, which (in comparison to chloroquine) results in a 500-fold enhancement of gene expression mediated by the (gal)Ccontaining DNA complexes (Figure 3) .
Instead of using whole viral particles, it would be desirable to generate completely synthetic gene transfer complexes that utilize cellular mechanisms for entry. We intended to separate the endosome-release function of viruses from the whole virus particles. In this context, we have recently demonstrated that small synthetic peptides derived from influenza virus hemagglutinin that are able to disrupt membranes specifically under acidic conditions, if included in DNA complexes, promote transferrinmediated gene transfer (11) . We have shown here that DNA complexes containing both the synthetic ligand for endocytosis, (gal)4, and the synthetic membrane-active influenza peptide can deliver genes to hepatocytes with an efficiency approximately 500-fold higher than complexes lacking the influenza peptide (Figure 41 Addition of the DNA complexes to the cells (in the absence of chloroquine) and further treatment of the cultures was performed as described in Figure 3A . Cell culture samples were harvested and assayed for luciferase activity as described in Figure 2 .
approximately 50-fold lower than with adenovirus particles ( Figure 3C ). Our synthetic ligand for the asialoglycoprotein receptor functions comparably to a natural ligand and, with respect to hepatocytes, even better than transferrin as ligand in gene-transfer experiments. We hope that gene-transfer systems containing synthetic, welldefined ligands such as the (gd)4 described here, combined in a modular manner with other functional components such as synthetic membrane-disrupting peptides, will prove useful for targeted gene-transfer applications.
